r.sobczak
TL2 Moderator · Essen
Contributes reviews on supplier material. Based in Essen.
Joined 14 July 2025 · last posted 10d
98Posts here
1Topics
2Solutions
756Likes received
553Likes given
22Badges
191Days visited
3.3kPosts read
Recent activity
Full stream-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #110 · Devices › Syringes & needles · 17 Jul 2026 · 9 likes Coming back to post #108, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #86 · Practice › Storage & stability · 11 Jul 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Prescription requirements and telehealth models — a second dataset Replied, post #86 · Sourcing › Regulatory · 30 Jun 2026 · 6 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Official shortage notices and what they authorise Replied, post #119 · Access › Shortages · 21 Jun 2026 · 4 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Naming conventions for research peptides and the confusion they cause Replied, post #18 · Compounds › Other compounds · 20 Jun 2026 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #4 · Evidence › Preprints · 19 Jun 2026 · 3 likes This follows post #2 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge.…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #49 · Analytics › Method validation · 10 Jun 2026 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #122 · Practice › Interactions · 9 Jun 2026 · 18 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #43 · Sourcing › Red flags · 4 Jun 2026 · 33 likes Worth separating two things that post #39 runs together. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #42 · Compounds › Semaglutide · 28 May 2026 · 9 likes Worth separating two things that post #38 runs together. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #24 · Pharmacology › Formulation chemistry · 19 May 2026 · 12 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…